当前位置: 首页 > 期刊 > 《中国医药导报》 > 2018年第21期
编号:1358111
江苏省医药制造业创新评价模型构建与实证
http://www.100md.com 2018年11月15日 中国医药导报 2018年第21期
     孙峰 王红杰 姜玮

    [摘要] 本文从江苏省医药产业发展现状出发,提出构建评价指标体系应遵循科学性、可操作性、清晰性原则,并提出建立由5个一级指标和10个二级指标、56个三级指标组成的医药制造业创新潜力评价指标体系。从创新基础、创新资源、创新投入、创新产出、创新效率等5个方面对医药制造业分地区创新潜力指标进行了分析,评判了江苏省医药制造业规模经济、创新投入、产出成果、社会需要、科技进步贡献等发展水平,结果表明连云港医药制造业呈现出快速发展的态势,总体发展优势明显,江苏省医药制造业已形成连云港、泰州和苏南三大产业集群区,苏南、苏中和苏北地区医药制造业发展均衡。

    [关键词] 医药制造业;创新评价;模型构建;评价实证

    [中图分类号] G312 [文献标识码] A [文章编号] 1673-7210(2018)07(c)-0159-08

    The construction and demonstration of the innovation evaluation model of the pharmaceutical industry in Jiangsu Province

    SUN feng WANG HONGjie JIANG wei

    Jiangsu Institute of Science and Technology Information, Jiangsu Province, Nanjing 210042, China

    [Abstract] This paper, starting from the current situation of the development of the pharmaceutical industry in Jiangsu Province, proposed that the evaluation index system should follow the principles of science, operability and clarity, and put forward the establishment of an evaluation index system for the innovation potential of the pharmaceutical manufacturing industry, consisting of 5 first grade indicators and 10 two level indicators and 56 three level indicators. From the 5 aspects of the innovation foundation ......

您现在查看是摘要页,全文长 18841 字符